We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Menopause authority guide
The choices that matter most for the next 30 years are made in the next 5.
Reviewed by the kindr Health medical team · Last reviewed July 15, 2026
This is the "30 years after" page. What you and your clinician decide now shapes your fracture risk in your 70s and your cardiac risk starting in your 60s.
Estrogen regulates osteoclast activity — the cells that break down bone. When estradiol drops at menopause, osteoclast activity accelerates and outpaces bone formation. Women lose about 10% of their total bone mass in the first 5–7 years after menopause [1]. This is the single largest bone-density event of most women's lives.
Half of women over 50 will have an osteoporosis-related fracture in their lifetime. Hip fracture in particular carries a 20–30% one-year mortality rate in older adults — this is not a cosmetic concern, it is a lifespan issue [1].
Cardiovascular disease is the leading cause of death for women in the United States [2]. Before menopause, estrogen contributes to favorable lipid profiles, vascular flexibility, and endothelial function. After menopause, LDL and total cholesterol rise, vascular stiffness increases, and cardiovascular event rates climb — reaching men's rates roughly a decade later [2][3].
The clinical concept of a "timing hypothesis" — that starting hormone therapy in appropriately selected women within 10 years of menopause and before age 60 is associated with different cardiovascular outcomes than starting it later — is discussed in current society guidance and is a conversation to have with a licensed provider familiar with the current evidence [4].
of total bone mass lost in the first 5–7 years post-menopause
Bone Health & Osteoporosis Foundationhigher LDL cholesterol trajectory during the menopause transition
Journal of the American College of Cardiology — Matthews et al.DEXA scan is the gold-standard measurement of bone density. USPSTF recommends screening women 65 and older, and postmenopausal women under 65 with clinical risk factors [1]. Ask your clinician when yours is appropriate.
Hormone therapy — most often systemic estradiol paired with progesterone for women with a uterus — is described by The Menopause Society and ACOG as the most effective treatment currently available for moderate-to-severe vasomotor symptoms in appropriately selected patients. Whether it is right for any individual is a clinical decision your provider makes with you, weighing symptom burden, age, time since menopause, and personal medical history. The Menopause Society specifically notes that in appropriately selected women, hormone therapy also protects bone density and reduces fracture risk. Prescribing decisions weigh benefits and risks individually [4].
For established osteoporosis, providers may discuss bisphosphonates or other bone-directed medications. For cardiovascular risk, a licensed provider evaluates lipids, blood pressure, glucose, family history, and may discuss statins or other therapies based on your calculated risk.
Educational information only. Prescription decisions are made by a licensed provider based on your individual medical history.
USPSTF recommends DEXA screening for women 65 and older, and earlier for postmenopausal women with clinical risk factors (low body weight, prior fracture, glucocorticoid use, family history, smoking, or early menopause). Ask your clinician [1].
In appropriately selected women, hormone therapy is well-established to protect bone density and reduce fracture risk. Cardiovascular effects depend on age, time since menopause, and individual risk — this is a clinical conversation, not a blanket recommendation [4].
They can be. Women more often present with fatigue, jaw or back pain, nausea, or shortness of breath — sometimes without classic chest pain. When in doubt, call 911 [2].
1,000–1,200 mg per day for postmenopausal women, preferably from food (dairy, leafy greens, fortified foods, canned fish with bones). Supplement to fill gaps, not replace food [1].
No — it is the ideal time to start. The prevention window is roughly the transition and the first decade after your final period. Waiting until you are 70 is too late for many of the most effective interventions.
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Reviewed by the Kindr Health medical team · Last reviewed 2026-07-15.